| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Descriptive Information Fields | |||||||||
| Brief Title † | Evaluation of the Causes and Disease Processes of Chronic Lung Disease | ||||||||
| Official Title † | Comprehensive Evaluation of the Etiology and Pathogenesis of Chronic Lung Disease (Screening Protocol) | ||||||||
| Brief Summary | Chronic lung diseases are disorders associated with abnormalities in any of the structures involved in the process of breathing and bringing oxygen into the lungs and blood. This includes abnormalities in the airways, lungs, blood vessels in and around the lungs, and the tissue covering the lungs (pleura). The purpose of this research study is to evaluate patients referred to the Pulmonary-Critical Care Medicine Branch (P-CCMB) of the National Heart, Lung, and Blood Institute (NHLBI) in order to;
|
||||||||
| Detailed Description | The chronic lung diseases are those disorders associated with functional and/or structural derangement to the alveolar structures, airways, pulmonary blood vessels, pleura and/or mediastinum. The purpose of this project is to permit the comprehensive evaluation of patients referred to the Pulmonary-Critical Care Medicine Branch (P-CCMB) in order to: (1) develop an understanding of the etiology and pathogenesis of these disorders; and (2) identify individuals who will be suitable candidates for other P-CCMB protocols. |
||||||||
| Study Phase | |||||||||
| Study Type † | Observational | ||||||||
| Study Design † | |||||||||
| Primary Outcome Measure † | |||||||||
| Secondary Outcome Measure † | |||||||||
| Condition † | Lung Disease | ||||||||
| Intervention † | |||||||||
| MEDLINE PMIDs | 438328, 495693, 7011012 | ||||||||
| Links | NIH Clinical Center Detailed Web Page  |
||||||||
| Recruitment Information Fields | |||||||||
| Recruitment Status † | Recruiting | ||||||||
| Enrollment † | |||||||||
| Start Date † | March 1982 | ||||||||
| Completion Date | |||||||||
| Eligibility Criteria † |
Symptoms consistent with pulmonary disease. May have family history of lung disease. Patients with diseases of organs with known association with lung disease. EXCLUSION CRITERIA: Persons with no clinical evidence of lung disease. |
||||||||
| Gender | Both | ||||||||
| Ages | 10 Years and older | ||||||||
| Accepts Healthy Volunteers | No | ||||||||
| Contacts †† |
|
||||||||
| Location Countries † | United States | ||||||||
| Administrative Information Fields | |||||||||
| NCT ID † | NCT00001183 | ||||||||
| Organization ID | 820032 | ||||||||
| Secondary IDs †† | 82-H-0032 | ||||||||
| Study Sponsor † | National Heart, Lung, and Blood Institute (NHLBI) | ||||||||
| Collaborators †† | |||||||||
| Investigators † | |||||||||
| Information Provided By | National Institutes of Health Clinical Center (CC) | ||||||||
| Verification Date | September 2008 | ||||||||
| First Received Date † | November 3, 1999 | ||||||||
| Last Updated Date | October 24, 2008 | ||||||||
|
